Jump to content

Kiran

Administrator
  • Content Count

    37,507
  • Donations

    $525.00 
  • Joined

  • Days Won

    7

Kiran last won the day on March 17 2018

Kiran had the most liked content!

3 Followers

About Kiran

  • Rank
    STAR
  • Birthday July 4

Contact Methods

  • Website URL
    Array

Profile Information

  • Gender
    Array
  • Location
    Array

Recent Profile Visitors

46,476 profile views
  1. If at all they will implement, they will merge schemes and implement
  2. Essar Steel promoters offer Rs 54,389 cr to clear all dues of banks New Delhi, Oct 25 (PTI) In a last-ditch effort to retain control over the company, promoters Ruia family Thursday offered to pay lenders of Essar Steel Rs 54,389 crore including Rs 47,507 crore upfront cash payment to clear all dues and pull out the firm from insolvency proceedings. The offer is better than Rs 42,202 crore offered by the world's largest steel producer ArcelorMittal to take over Essar Steel, which lenders are auctioning to recover their unpaid dues of over Rs 49,000 crore. "The shareholders of Essar Steel have today (Thursday) submitted a proposal to the Committee of Creditors (CoC) for full settlement of the entire admitted claims of the financial creditors, operational creditors, and workmen and employees of Essar Steel India Ltd (ESIL), aggregating Rs 54,389 crore, under Section 12A of the Insolvency and Bankruptcy Code," the company said in a statement. While the company did not share where it was raising the money from, sources said the promoters have already arranged for an upfront cash payment to save the biggest mill being sold under the new insolvency process. Ruias offered to pay financial creditors a total of Rs 49,395 crore to clear all their outstanding dues till date. Besides operational creditors have been offered Rs 4,976 crore and employees another Rs 18 crore to clear all their dues. https://www.businesstoday.in/pti-feed/essar-steel-promoters-offer-rs-54389-cr-to-clear-all-dues-of-banks/story/286566.html
  3. More than 116,000 beneficiaries have been treated since its launch. Payments to the hospitals is being done based on pre-defined package rates by the Govt or the insurance co.
  4. The target is not middle class. The criteria based on 2011 scec not current. extension to 50cr families or alternative options might come at later time
  5. Dr Dinesh Arora‏ @drdineshias Oct 7 2 weeks of #AyushmanBharat #PMJAY & major milestone achieved. >50000 poor patients treated/admitted in empanelled hospitals. Dr. Indu Bhushan‏ @ibhushan Delighted to share another #AyushmanBharat milestone. We have issued more than 1 Lakh #PMJAY eCards to beneficiaries. 100188 Golden Records made so far!
  6. Ayushman Bharat can be a model to develop low cost healthcare systems in other parts of the world: GE Healthcare GE Healthcare, one of world's largest medical device company is closely watching the developments of the Ayushman Bharat, as it thinks if this scheme succeeds it can be a model to develop low cost healthcare systems across the developing world. Kieran Murphy, CEO and President of GE Healthcare who is in India for the first time after taking charge of the company last year, said that as governments across the world look at getting the most out of their systems, the company is working towards developing products that drives healthcare productivity at lower cost. The flagship insurance scheme of the current NDA government that promises to cover 40 million Indians with a insurance cover of Rs 5 lakh, has attracted the likes of all healthcare providers who are hoping to cash on with their solutions to the massive healthcare scheme. GE is no different. "As we look at Ayushman Bharat, I think this starts to work, we can really develop systems around healthcare that can drive down cost, it is going to be extremely powerful for healthcare around the world", Murphy said. The one year old CEO of the $20billion medical device company is in the middle of a spin off as it fights off competition from its rivals like Siemens and Phillips among others in its imaging business. Localisation is an important part of GE's business, Murphy explained as it looks to bring variable cost in India to drive cost and improve productivity. Part of this strategy is an collaboration that the company has entered with SAMEER, an R&D unit under Department of Electronics and Information Technology on research, design and development of a 1.5T MRI platform. The clinical trial is expected to start by end of 2019. SAMEER has received a funding of $6 million from the government to build the first prototype. This is first of its kind industry collaboration for the research body that is based out of IIT Bombay. "We create capacity in an industry that is growing through huge amount of change in developing world where you are going to see 1 or 2 billion people in the next 10 years entering, effectively a brand new market for healthcare". Every single government around the world is looking at bringing down cost of healthcare. That is why scale of GE is helpful for us, because we can talk to governments across the world about how we can use initiatives of GE to improve productivity", Murphy told ET. One of the key aspects of India healthcare market according to GE is how healthcare providers are looking at ways to squeeze cost out of every procedure- right from a complex heart surgery or through diagnosis. Some of our customers that we met, Murphy said are masters in trying to drive productivity. https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/ayushman-bharat-can-be-a-model-to-develop-low-cost-healthcare-systems-in-other-parts-of-the-world-ge-healthcare/articleshow/66125192.cms
  7. Ee filters pedithene 10koka families aa varini Hope they will expand slowly to other people by increasing budget
  8. Blank statements iche badhulu supporting data pettara how Pharma is down. Nenu chusina reports anni pointing towards increased growth rate. Jan Aushadi centres are disrupting few Pharma business model. Other than that I don’t see anything of major concern in this sector.
  9. Obamacare ke dikku divana ledhu daniki malli copy kuda
  10. Exports of pharmaceuticals products from India increased from US$6.23 billion in 2006-07 to US$8.7 billion in 2008-09 a combined annual growth rate of 21.25%. India exported $11.7 billion worth of pharmaceuticals in 2014. Pharmaceutical export from India stood at US$ 17.27 billion in 2017-18, and is expected to grow by 30 per cent to reach US$ 20 billion by the year 2020.
×